The EAG is commissioned by NICE to provide independent assessment of the evidence for medical technologies and related economic analysis, as well as providing methodological and analytical support to NICE.
The Medical Technologies Evaluation Programme (MTEP) selects and evaluates new or innovative medical technologies (including devices and diagnostics). MTEP helps the NHS adopt efficient and cost-effective medical devices and diagnostics more rapidly and consistently.
We also have a central role in developing and facilitating independent research products when NICE medical technology or diagnostics guidance recommends that further research should be carried out.
The EMU is commissioned by NICE to produce the economic analyses, associated economic models and cost-effectiveness reviews to aid NICE's Public Health Advisory Committees in guideline development. In addition, the EMU is commissioned to carry out projects to address methodological issues identified by the PHSCC.
NICE public health guidelines make recommendations on interventions that can help prevent disease or improve health. The guidelines are aimed at public health professionals, practitioners and others with a direct or indirect role in public health. This may be within the NHS, local authorities, the wider public, voluntary, community and private sectors.
YHEC develops models for around five guidelines each year as well as methods papers, and some examples of our work are included below:
Models for public health guidelines
YHEC was commissioned to develop an approach to the assessment of the cost-effectiveness of new indicators for the Quality and Outcomes Framework (QOF). YHEC provided economic analysis to the NICE Indicator Advisory Committee twice yearly for new performance indicators, which were piloted and assessed by the University of Birmingham. This involved net benefit analysis of the impact of incentivising primary care to adopt relevant NICE recommendations across a range of diseases and conditions.